Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:conestat_alfa
|
| gptkbp:approvalYear |
2014
|
| gptkbp:approvedBy |
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration |
| gptkbp:ATCCode |
B06AC04
|
| gptkbp:countryOfOperation |
gptkb:European_Union
gptkb:United_States |
| gptkbp:form |
powder for solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ruconest
|
| gptkbp:indication |
acute attacks of hereditary angioedema
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pharming_Group_NV
|
| gptkbp:mechanismOfAction |
C1 esterase inhibitor replacement
|
| gptkbp:origin |
recombinant protein produced in transgenic rabbits
|
| gptkbp:pregnancyCategory |
not established
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fever
nausea diarrhea headache rash |
| gptkbp:storage |
2-8°C
|
| gptkbp:usedFor |
gptkb:hereditary_hemorrhagic_telangiectasia
|
| gptkbp:bfsParent |
gptkb:C1_inhibitor_concentrate
gptkb:Valeant_Pharmaceuticals_International |
| gptkbp:bfsLayer |
7
|